Orexo Neuro

💊 Neuropharmaceuticals· 📍 Uppsala, Sweden

Overview

Orexo develops sublingual and digital-therapeutic combination products targeting opioid use disorder and central nervous system conditions.

Neurogenix Therapeutics

Basel, Switzerland

Acadia Pharmaceuticals

San Diego, USA

Acer Therapeutics

Newton, MA, USA

Praxis Precision Medicine

Cambridge, MA, USA

Axsome Therapeutics

New York, USA

BioXcel Therapeutics

New Haven, CT, USA

It's Finally Here: FacialDx, an AI-Powered Support Tool for Sideline Concussion Assessments

2026-06-23 · Product

MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy

2026-06-13 · Research

Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings

2026-06-11 · Product

Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial

2026-06-09 · Industry

Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.

Advertise

Newsletter sponsorships, featured listings, and sponsored articles.